Botulinum Toxin Injections
J15
31 active Medicare policies list 95873, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 95873 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Post-Herpetic Neuralgia | Feb 20, 2024 | Covered |
| Policy | Effective | Status of 95873 |
|---|---|---|
| CMM-205: Chemodenervation-Botulinum ToxinEffective 08/11/2017 - 10/21/2018 | Aug 11, 2017 | Covered |
| Policy | Effective |
|---|
J5
J8 · Effective Feb 22, 2026
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Oct 1, 2026
National · Effective May 7, 2026
J5 · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
| Status of 95873 |
|---|
| Neurophysiologic Testing and Monitoring | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 95873 |
|---|---|---|
| Neurophysiologic Testing and Monitoring | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 95873 |
|---|---|---|
| Neurophysiologic Testing and Monitoring | Jan 1, 2026 | Covered |